Psychiatric Assessment and
Diagnosis Overview
Separation Anxiety Disorder ANS: Fear of separation from attachment figures.
Panic Disorder ANS: Recurrent unexpected panic attacks.
Dhat Syndrome ANS: Cultural syndrome related to semen loss.
Executive Functions ANS: Cognitive processes for organizing and initiating tasks.
MOCA Score of 5 ANS: Indicates severe memory impairment and disorientation.
Delirium ANS: Characterized by sudden onset of confusion.
Acetylcholinesterase Inhibitors ANS: Medications often discontinued due to gastrointestinal side
effects.
Huntington's Disease ANS: Neurocognitive disorder with onset at age 40.
Cultural Stigma ANS: Negative societal attitudes towards mental illness.
Somatic Complaints ANS: Physical symptoms without medical explanation.
Nightmares ANS: Disturbing dreams causing anxiety or fear.
Ataxia ANS: Lack of voluntary coordination of muscle movements.
,Postural Instability ANS: Difficulty maintaining balance and posture.
Illness Anxiety Disorder ANS: Preoccupation with having a serious illness.
Specific Phobia ANS: Intense fear of a specific object or situation.
Gastrointestinal Side Effects ANS: Common reason for discontinuing certain medications.
Cognitive Decline ANS: Gradual loss of cognitive abilities over time.
Mood Disorders ANS: Psychological disorders affecting emotional state.
Nighttime Fears ANS: Anxiety about dangers when alone at night.
Social Engagement ANS: Ability to interact and connect with others.
Memory Difficulty ANS: Challenges in recalling information or experiences.
Fatigue and Weakness ANS: Common symptoms reported in Dhat syndrome.
Motor Symptoms ANS: Physical symptoms affecting movement and coordination.
Affective Regulations ANS: Managing emotions in response to stimuli.
, Montreal Cognitive Assessment ANS: A screening tool for cognitive impairment.
Mini Mental State Examination ANS: A test assessing cognitive function and orientation.
Mild Cognitive Impairment ANS: Early stage of cognitive decline, not severe.
Pseudo Dementia ANS: Cognitive impairment mimicking dementia, often reversible.
Major Neurocognitive Disorder ANS: Significant cognitive decline affecting daily functioning.
Normal Aging ANS: Natural cognitive changes occurring with age.
Cholinesterase Inhibitor ANS: Medications that increase acetylcholine levels in the brain.
Rivastigmine ANS: A cholinesterase inhibitor used for Alzheimer's treatment.
Common Side Effects ANS: Adverse reactions patients may experience from medications.
Gait Ataxia ANS: Loss of coordination affecting walking ability.
Cerebellum ANS: Brain region responsible for coordination and balance.
Major Depressive Disorder ANS: Severe mood disorder affecting daily life.
Fluctuating Levels of Alertness ANS: Variability in consciousness and awareness over time.
Diagnosis Overview
Separation Anxiety Disorder ANS: Fear of separation from attachment figures.
Panic Disorder ANS: Recurrent unexpected panic attacks.
Dhat Syndrome ANS: Cultural syndrome related to semen loss.
Executive Functions ANS: Cognitive processes for organizing and initiating tasks.
MOCA Score of 5 ANS: Indicates severe memory impairment and disorientation.
Delirium ANS: Characterized by sudden onset of confusion.
Acetylcholinesterase Inhibitors ANS: Medications often discontinued due to gastrointestinal side
effects.
Huntington's Disease ANS: Neurocognitive disorder with onset at age 40.
Cultural Stigma ANS: Negative societal attitudes towards mental illness.
Somatic Complaints ANS: Physical symptoms without medical explanation.
Nightmares ANS: Disturbing dreams causing anxiety or fear.
Ataxia ANS: Lack of voluntary coordination of muscle movements.
,Postural Instability ANS: Difficulty maintaining balance and posture.
Illness Anxiety Disorder ANS: Preoccupation with having a serious illness.
Specific Phobia ANS: Intense fear of a specific object or situation.
Gastrointestinal Side Effects ANS: Common reason for discontinuing certain medications.
Cognitive Decline ANS: Gradual loss of cognitive abilities over time.
Mood Disorders ANS: Psychological disorders affecting emotional state.
Nighttime Fears ANS: Anxiety about dangers when alone at night.
Social Engagement ANS: Ability to interact and connect with others.
Memory Difficulty ANS: Challenges in recalling information or experiences.
Fatigue and Weakness ANS: Common symptoms reported in Dhat syndrome.
Motor Symptoms ANS: Physical symptoms affecting movement and coordination.
Affective Regulations ANS: Managing emotions in response to stimuli.
, Montreal Cognitive Assessment ANS: A screening tool for cognitive impairment.
Mini Mental State Examination ANS: A test assessing cognitive function and orientation.
Mild Cognitive Impairment ANS: Early stage of cognitive decline, not severe.
Pseudo Dementia ANS: Cognitive impairment mimicking dementia, often reversible.
Major Neurocognitive Disorder ANS: Significant cognitive decline affecting daily functioning.
Normal Aging ANS: Natural cognitive changes occurring with age.
Cholinesterase Inhibitor ANS: Medications that increase acetylcholine levels in the brain.
Rivastigmine ANS: A cholinesterase inhibitor used for Alzheimer's treatment.
Common Side Effects ANS: Adverse reactions patients may experience from medications.
Gait Ataxia ANS: Loss of coordination affecting walking ability.
Cerebellum ANS: Brain region responsible for coordination and balance.
Major Depressive Disorder ANS: Severe mood disorder affecting daily life.
Fluctuating Levels of Alertness ANS: Variability in consciousness and awareness over time.
